Yahoo Web Search

Search results

    • Why Wall Street Is Chasing Ozempic Wannabes

      Why Wall Street Is Chasing Ozempic Wannabes

      The Wall Street Journal· 6 hours ago

      HEARD ON THE STREET Gilead Sciences a biotech company focused on treatments for cancer and HIV, isn’t pitching itself as an obesity-drug developer. But...

    • Kerry Lonsdale | Bookreporter.com

      Book Reporter· 25 minutes ago

      Kerry Lonsdale is the Amazon Charts, Wall Street Journal, Washington Post and #1 Kindle bestselling author of the Everything series, No More trilogy and ...

    • Why Wall Street Is Chasing Ozempic Wannabes

      Why Wall Street Is Chasing Ozempic Wannabes

      The Wall Street Journal· 6 hours ago

      Gilead Sciences, a biotech company focused on treatments for cancer and HIV, isn’t pitching itself as an obesity-drug developer. But that hasn’t stopped...